Fresenius Kabi USA LLCMay 18, 2020

FDA 483 - Fresenius Kabi USA LLC - May 18, 2020

FDA 483 for Fresenius Kabi USA LLC on May 18, 2020. Product: Drugs. Access full analysis and detailed observations.

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA 483 for Fresenius Kabi USA LLC on May 18, 2020. Product: Drugs. Access full analysis and detailed observations.

Violation Codes

21 CFR 211.113

21 CFR 211

21 CFR 211.67

21 CFR 211.111

21 CFR 211.100

21 CFR 211.192

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Fresenius Kabi USA LLC

Inspection Date

May 18, 2020

Product Type

Drugs

Office

Chicago District Office

People

ID: d336177f-cc20-4bc6-a876-9138e3d07f5a

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox